INNOVUS PHARMACEUTICALS, INC. Debt Instrument, Convertible, Beneficial Conversion Feature
INNOVUS PHARMACEUTICALS, INC. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $2.76 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2016-11-14
- INNOVUS PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-09-30 was $1.82M, a 2444.09% increase year-over-year.
- INNOVUS PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-06-30 was $937.01K.
- INNOVUS PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2016-03-31 was $1.83K.
- INNOVUS PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for the quarter ending 2015-09-30 was $71.46K.
- INNOVUS PHARMACEUTICALS, INC. debt instrument, convertible, beneficial conversion feature for fiscal 2013 was $98.33K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 3 month | Debt Instrument, Convertible, Beneficial Conversion Feature 6 month | Debt Instrument, Convertible, Beneficial Conversion Feature 9 month | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|---|---|---|
| 2016-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.76M derived: sum of 2 quarters · filed 2016-11-14 | $2.76M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $937.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $938.84K 10-Q · filed 2016-08-15 | ||
| 2016-03-31 | $1.83K 10-Q · filed 2016-05-16 | |||
| 2015-09-30 | $71.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $71.46K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 | |||
| 2013-12-31 | $98.33K 10-K · filed 2014-03-28 |